Testing the Addition of Nivolumab to Chemotherapy for Patients With Metastatic Anal Cancer

Conditions:   Anal Basaloid Carcinoma;   Anal Canal Cloacogenic Carcinoma;   Metastatic Anal Squamous Cell Carcinoma;   Recurrent Anal Squamous Cell Carcinoma;   Stage III Anal Cancer AJCC v8;   Stage IIIA Anal Cancer AJCC v8;   Stage IIIB Anal Cancer AJCC v8;   Stage IIIC  Anal Cancer AJCC v8;   Stage IV Anal Cancer AJCC v8 Interventions:   Drug: Carboplatin;   Biological: Nivolumab;   Drug: Paclitaxel Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials